NIH-funded research U01 cooperative agreement

Smoking cessation support for people with HIV in South Africa

Official title: Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.

Funded at Johns Hopkins University · NIH-11419226 · Data updated 2026-11-12

A Johns Hopkins-led effort tests practical, proven smoking-cessation approaches with people living with HIV in South Africa to see if they work well in that setting and are worth expanding.

More Smoking research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 15, 2021
Project endAugust 31, 2027
Funding year2026
Award (this year)$440,956
NIH project number5U01CA261626-06
Project IDNIH-11419226 on NIH RePORTER

Who could benefit from this research

Could help

Adults living with HIV in South Africa who smoke and are eligible for smoking-cessation interventions.

Less likely to help

Smokers unaware of their HIV status or those not engaged in HIV care may not directly benefit.

What this research studies

This project aims to optimize a smoking cessation program for people with HIV in South Africa by testing how well the interventions work, how easily they can be put into practice, and whether they are cost-effective. It builds on strategies that have succeeded in other low-resource settings and considers the local TB and cardiovascular risks that smoking adds for people living with HIV. The study will look at real-world delivery in primary care and ART clinics, focusing on implementation and sustainability in addition to efficacy. The findings could inform policy and clinical guidelines to reduce smoking-related health burdens in South Africa and similar contexts.

Why it matters

Potential benefit: If successful, the program could reduce smoking-related illnesses and extend the healthy life span of people living with HIV in South Africa.

How similar studies have gone: Previous studies in other low-resource settings show promise for these interventions, supporting the potential for successful translation to similar populations.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Golub, Jonathan E. — Johns Hopkins University
  • Study coordinator: Golub, Jonathan E.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.